Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peep V Algvere

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Acta Ophthalmologica Scandinavica|September 27, 2003
Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss?Peep V Algvere, Stefan Seregard
Acta Ophthalmologica Scandinavica|April 16, 2002
Age-related maculopathy: pathogenetic features and new treatment modalitiesPeep V Algvere, Stefan Seregard
Acta Ophthalmologica|May 24, 2008
Shall we use Avastin or Lucentis for ocular neovascularization?Peep V Algvere, Anders Kvanta, Stefan Seregard
Acta Ophthalmologica Scandinavica|February 1, 2006
Age-related maculopathy and the impact of blue light hazardPeep V Algvere, John Marshall, Stefan Seregard
Survey of Ophthalmology|September 5, 2006
Photochemical damage of the retinaJiangmei Wu, Stefan Seregard, Peep V Algvere
Acta Ophthalmologica|March 25, 2016
Drusen maculopathy: a risk factor for visual deteriorationPeep V Algvere, Anders Kvanta, Stefan Seregard
Acta Ophthalmologica|December 29, 2007
A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durationsPeep V Algvere, Björn Steén, Stefan Seregard, et al.
Acta Ophthalmologica Scandinavica|August 23, 2002
Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal spaceSven Crafoord, Lijun Geng, Stefan Seregard, et al.
Acta Ophthalmologica Scandinavica|May 20, 2003
Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-upPeep V Algvere, Carina Libert, Gunnar Lindgärde, et al.
Acta Ophthalmologica|July 6, 2010
Vision-related function after low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degenerationAnne Odergren, Peep V Algvere, Stefan Seregard, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Acta Ophthalmologica Scandinavica|September 27, 2003
Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss?Peep V Algvere, Stefan Seregard
Acta Ophthalmologica Scandinavica|April 16, 2002
Age-related maculopathy: pathogenetic features and new treatment modalitiesPeep V Algvere, Stefan Seregard
Acta Ophthalmologica|May 24, 2008
Shall we use Avastin or Lucentis for ocular neovascularization?Peep V Algvere, Anders Kvanta, Stefan Seregard
Acta Ophthalmologica Scandinavica|February 1, 2006
Age-related maculopathy and the impact of blue light hazardPeep V Algvere, John Marshall, Stefan Seregard
Survey of Ophthalmology|September 5, 2006
Photochemical damage of the retinaJiangmei Wu, Stefan Seregard, Peep V Algvere
Acta Ophthalmologica|March 25, 2016
Drusen maculopathy: a risk factor for visual deteriorationPeep V Algvere, Anders Kvanta, Stefan Seregard
Acta Ophthalmologica|December 29, 2007
A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durationsPeep V Algvere, Björn Steén, Stefan Seregard, et al.
Acta Ophthalmologica Scandinavica|August 23, 2002
Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal spaceSven Crafoord, Lijun Geng, Stefan Seregard, et al.
Acta Ophthalmologica Scandinavica|May 20, 2003
Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-upPeep V Algvere, Carina Libert, Gunnar Lindgärde, et al.
Acta Ophthalmologica|July 6, 2010
Vision-related function after low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degenerationAnne Odergren, Peep V Algvere, Stefan Seregard, et al.
Pageof 2